SCHEDULE 13D

Company

Sonoma Pharmaceuticals, Inc.

Filed

March 23, 2015

Accession Number

0001019687-15-001066

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →